TGF-β levels significantly increases in patients with stage III and IV breast cancer and can be explored as a target for tumour diagnosis and staging

Scand J Immunol. 2023 Aug;98(2):e13280. doi: 10.1111/sji.13280. Epub 2023 May 10.
No abstract available

Publication types

  • Letter

MeSH terms

  • Breast Neoplasms* / diagnosis
  • Breast Neoplasms* / pathology
  • Female
  • Humans
  • Neoplasm Staging
  • Transforming Growth Factor beta

Substances

  • Transforming Growth Factor beta